SCHEMBL31545877

SCHEMBL31545877

CC(CCCc1ccc(F)cc1)c1cc(O)c2c(c1)OC(C)(C)C1=C2CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11738579 1.00 — —
SCHEMBL11738988 0.90 CNR1 (0.42) —
SCHEMBL11336617 0.87 — —
Hydrochloric Acid SCHEMBL11704170 0.87 — —
SCHEMBL11735384 0.87 CNR1 (0.59) —
SCHEMBL11738564 0.85 — —
SCHEMBL11774583 0.84 CNR2 (0.56) —
SCHEMBL31545535 0.84 CNR1 (0.61) —
SCHEMBL11639903 0.84 — —
SCHEMBL11706837 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback